Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Gardner named CEO of Flagship’s Ampersand

Plus: Brian Powl joins Kura as CCO, and updates from BioNTech, Allogene, CG and more

August 14, 2023 11:26 PM UTC

Jason Gardner joined Flagship Pioneering as CEO-partner, while becoming CEO and board member at portfolio company Ampersand Biomedicines Inc. Gardner, a 10-year veteran of GSK plc (LSE:GSK; NYSE:GSK), was most recently president and CEO of Magenta Therapeutics Inc. (NASDAQ:MGTA), which he co-founded.

Brian Powl was named chief commercial officer (CCO) at Kura Oncology Inc. (NASDAQ:KURA), which is developing precision medicines for cancer. Powl was most recently CCO at Fate Therapeutics Inc. (NASDAQ:FATE)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article